Sage Journals: Discover world-class research

Abstract

It is likely that the enhancement of signaling after antigenic stimulation, particularly in the tumor microenvironment, would improve the function of adoptively transferred T cells. Linker for activation of T cells (LAT) plays a central role in T cell activation. We hypothesized that the ubiquitylation-resistant form of LAT in cells would enhance T cell signaling and thus augment antitumor activity. To test this, human CD4⁺ or CD8⁺ T cells were electroporated with small interfering RNA (siRNA) to repress endogenous LAT and ubiquitylation-resistant LAT 2KR or wild-type LAT mRNA was introduced for reexpression. Significantly enhanced phosphorylation of LAT and phospholipase C-γ (PLCγ) was observed, and augmented calcium signaling after T cell receptor (TCR) triggering was observed in LAT 2KR-expressing T cells. TCR-induced calcium signaling was abrogated in LAT knockdown cells, but the baseline was higher than that of control siRNA-electroporated cells, suggesting a fundamental requirement of LAT to maintain calcium homeostasis. Redirected LAT 2KR T cells expressing a chimeric antigen receptor or an MHC class I-restricted TCR showed augmented function as assessed by enhanced cytokine secretion and cytotoxicity. These results indicate that interruption of LAT ubiquitylation is a promising strategy to augment effector T cell function for adoptive cell therapy.

Get full access to this article

View all access options for this article.

References

Balagopalan

, Ashwell

B.A.

, Bernot

K.M.

et al. 2011. Enhanced T-cell signaling in cells bearing linker for activation of T-cell (LAT) molecules resistant to ubiquitylation. Proc. Natl. Acad. Sci. U.S.A., 108:2885–2890.

Barrett

D.M.

, Zhao

, Liu

et al. 2011. Treatment of advanced leukemia in mice with mRNA engineered T cells. Hum. Gene Ther., 22:1575–1586.

Bonini

, Brenner

M.K.

, Heslop

H.E.

, Morgan

R.A.

2011. Genetic modification of T cells. Biol. Blood Marrow Transplant., 17:S15–S20.

Cao

L.F.

, Krymskaya

, Tran

et al. 2010. Development and application of a multiplexable flow cytometry-based assay to quantify cell-mediated cytolysis. Cytometry A, 77:534–545.

Carpenito

, Milone

M.C.

, Hassan

et al. 2009. Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proc. Natl. Acad. Sci. U.S.A., 106:3360–3365.

Chiang

J.Y.

, Jang

I.K.

, Hodes

, Gu

2007. Ablation of Cbl-b provides protection against transplanted and spontaneous tumors. J. Clin. Invest., 117:1029–1036.

Constant

, Pfeiffer

, Woodard

et al. 1995. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4⁺ T cells. J. Exp. Med., 182:1591–1596.

Friberg

, Bryant

, Whiteside

. 1996. Measurements of Natural Killer (NK) Activity and NK-Cell Quantification. Methods, 9:316–26.

Greenberg

P.D.

, Riddell

S.R.

1999. Deficient cellular immunity—finding and fixing the defects. Science, 285:546–551.

10.

Hochweller

, Wabnitz

, Samstag

et al. 2010. Dendritic cells control T cell tonic signaling required for responsiveness to foreign antigen. Proc. Natl. Acad. Sci. U.S.A., 107:5931.

11.

Horejsi

, Zhang

, Schraven

2004. Transmembrane adaptor proteins: Organizers of immunoreceptor signalling. Nat. Rev. Immunol., 4:603–616.

12.

Johnson

L.A.

, Morgan

R.A.

, Dudley

M.E.

et al. 2009. Gene therapy with human and mouse T cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood, 114:535–546.

13.

June

C.H.

, Moore

J.S.

2004. Measurement of intracellular ions by flow cytometry. Curr. Protoc. Immunol.Chapter 5, Unit 5.5.

14.

Kalos

, Levine

B.L.

, Porter

D.L.

et al. 2011. T cells expressing chimeric receptors establish memory and potent antitumor effects in patients with advanced leukemia. Sci. Transl. Med., 3:95ra73.

15.

Kessels

H.W.

, Wolkers

M.C.

, Van Den Boom

et al. 2001. Immunotherapy through TCR gene transfer. Nat.Immunol., 2:957–961.

16.

Kohn

D.B.

, Dotti

, Brentjens

et al. 2011. CARS on track in the clinic: Report of a meeting organized by the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Sub-Committee on Cell and Gene Therapy. Washington D.C., May 18, 2010. Mol. Ther., 19:432–438.

17.

Krause

, Guo

H.F.

, Latouche

J.B.

et al. 1998. Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes. J. Exp. Med., 188:619–626.

18.

Lillemeier

, Mörtelmaier

, Forstner

et al. 2010. TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation. Nat. Immunol., 11:90–96.

19.

Malissen

, Aguado

, Malissen

2005. Role of the LAT adaptor in T-cell development and Th2 differentiation. Adv. Immunol., 87:1–25.

20.

Milone

M.C.

, Fish

J.D.

, Carpenito

et al. 2009. Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol. Ther., 17:1453–1464.

21.

Mingueneau

, Roncagalli

, Gregoire

et al. 2009. Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function independently of the T cell receptor. Immunity, 31:197–208.

22.

Munson

M.E.

2010. An improved technique for calculating relative response in cellular proliferation experiments. Cytometry A, 77:909–910.

23.

Nakayama

, Yamashita

2010. The TCR-mediated signaling pathways that control the direction of helper T cell differentiation. Semin. Immunol., 22:303–309.

24.

Paulos

C.M.

, Carpenito

, Plesa

et al. 2010. The inducible costimulator ICOS is critical for the development of human TH17 cells. Sci. Transl. Med., 2:55–78.

25.

Paz

P.E.

, Wang

, Clarke

et al. 2001. Mapping the Zap-70 phosphorylation sites on LAT (linker for activation of T cells) required for recruitment and activation of signalling proteins in T cells. Biochem. J., 356:461–471.

26.

Pierce

N.W.

, Kleiger

, Shan

S.O.

, Deshaies

R.J.

2009. Detection of sequential polyubiquitylation on a millisecond timescale. Nature, 462:615–619.

27.

Riese

M.J.

, Grewal

, Das

et al. 2011. Decreased diacylglycerol metabolism enhances ERK activation and augments CD8⁺ T cell functional responses. J. Biol. Chem., 286:5254–5265.

28.

Roederer

, Moore

, Treister

et al. 2001. Probability binning comparison: A metric for quantitating multivariate distribution differences. Cytometry, 45:47–55.

29.

Roncagalli

, Mingueneau

, Gregoire

et al. 2010. Lymphoproliferative disorders involving T helper effector cells with defective LAT signalosomes. Semin. Immunopathol., 32:117–125.

30.

Sadelain

, Riviere

, Brentjens

2003. Targeting tumours with genetically enhanced T lymphocytes. Nat. Rev. Cancer, 3:35–45.

31.

Schumacher

T.N.

2002. T-cell-receptor gene therapy. Nat. Rev. Immunol., 2:512–519.

32.

Shen

, Chuck

M.I.

, Zhu

et al. 2010. The importance of LAT in the activation, homeostasis, and regulatory function of T cells. J. Biol. Chem., 285:35393–35405.

33.

Sherman

, Barr

, Manley

et al. 2011. Functional nanoscale organization of signaling molecules downstream of the T cell antigen receptor. Immunity, 35:705–720.

34.

Simeoni

, Lindquist

J.A.

, Smida

et al. 2008. Control of lymphocyte development and activation by negative regulatory transmembrane adapter proteins. Immunol. Rev., 224:215–228.

35.

Zehn

, Lee

S.Y.

, Bevan

M.J.

2009. Complete but curtailed T-cell response to very low-affinity antigen. Nature, 458:211–214.

36.

Zhang

, Sloan-Lancaster

, Kitchen

et al. 1998. LAT: The ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell, 92:83–92.

37.

Zhang

, Trible

R.P.

, Zhu

et al. 2000. Association of Grb2, Gads, and phospholipase C-γ1 with phosphorylated LAT tyrosine residues: Effect of LAT tyrosine mutations on T cell angigen receptor-mediated signaling. J. Biol. Chem., 275:23355–23361.

38.

Zhao

, Zheng

, Robbins

P.F.

et al. 2005. Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell lines. J. Immunol., 174:4415–4423.

39.

Zhao

, Zheng

, Cohen

C.J.

et al. 2006. High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol. Ther., 13:151–159.

40.

Zhao

, Moon

, Carpenito

et al. 2010. Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. Cancer Res., 70:9062–9072.

41.

Zhu

, Janssen

, Zhang

2003. Minimal requirement of tyrosine residues of linker for activation of T cells in TCR signaling and thymocyte development. J. Immunol., 170:325–333.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.04 MB

0.08 MB

0.13 MB

0.09 MB

Enhanced Function of Redirected Human T Cells Expressing Linker for Activation of T Cells That Is Resistant to Ubiquitylation

Abstract

Get full access to this article

References

Supplementary Material